Related Experiment Video

Updated: May 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients

Zekeriya Nurkalem, Özlem Yildirimtürk, Kazim Serhan Özcan1

  • 1Bezmialem Vakif University, Faculty of Medicine, Cardiology Department, Istanbul/Turkey. serhandr@gmail.com.

Kardiologia Polska
|October 22, 2013
PubMed

Insights

Rosuvastatin did not affect erectile dysfunction in hypercholesterolemic men, but atorvastatin worsened it. Different statin medications may impact erectile function differently.

Area of Science:

  • Cardiology
  • Endocrinology
  • Urology

Background:

  • Hypercholesterolemia is a risk factor for cardiovascular disease and may impact erectile function.
  • Statins are commonly prescribed to manage hypercholesterolemia.
  • The potential differential effects of statins on erectile function require investigation.

Purpose of the Study:

  • To compare the effects of atorvastatin and rosuvastatin on erectile dysfunction in hypercholesterolemic patients.
  • To assess changes in erectile function using the International Index of Erectile Function-5 (IIEF-5) score.

Main Methods:

  • Prospective study of 90 male hypercholesterolemic patients without other cardiovascular risk factors.
  • Patients were randomized to receive either atorvastatin or rosuvastatin for six months.
  • Erectile function (IIEF-5 score) and blood parameters were evaluated at baseline and after six months.

Main Results:

  • No significant differences in baseline demographics, lipid profiles, or IIEF-5 scores between groups.
  • Rosuvastatin treatment showed no significant change in IIEF-5 scores after six months.
  • Atorvastatin treatment resulted in a significant decrease in IIEF-5 scores (p = 0.019).

Conclusions:

  • Rosuvastatin appears to have a neutral effect on erectile function in this patient cohort.
  • Atorvastatin use was associated with an increase in erectile dysfunction.
  • The findings suggest that different statin medications may exert varying effects on erectile function.
Abstract

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.4K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
387
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
842
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
406
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K